The
rise in non-communicable, inflammatory diseases (NCD), and in particular
allergic and atopic illnesses, has begun to redirect the efforts of the
clinical research community toward early prevention in addition to supportive
intervention. This is in light of the
significant burden on healthcare created by NCD as well as the realization of
the limitations of pharmacotherapies to affect underlying causes.
This
month’s review article by Pfefferle, Prescott and Kopp (J Allergy Clin Immunol 2013; 131(6): 1453-1463) assesses the
practical application of findings that commensal gut microbes are critical
partners in the evolution of environmental tolerance. They focus on the accumulating evidence
supporting a disrupted human microbiome that has led researchers to propose the
use of pro- and pre-biotic therapies as means to prevent inflammatory immune
processes that create chronic allergic and atopic diseases.
Pfefferle
et al. review briefly the current knowledge on the collaboration of the gut and
the immune system in developing tolerance, pointing out the importance of
maternal exposure to both pathogenic and non-pathogenic microbes in directing
fetal immunity. They note that high
prenatal exposure has been shown to have an independent protective effect on allergic
outcomes and that these effects are epigenetic.
Citing a study that compared the immune status and responsiveness of
urban Australian children with native Papua New Guinea children, Pfefferle
discuss the higher immune activation but lower reactivity of the Papua New
Guinea children compared to their urban counterparts, an observation that
points to highly divergent microbial exposure of the mothers and their
children.
The
authors go on to cover the research on maternal pro- and prebiotic
interventions for eczema and food allergies.
At least half of the maternal probiotic intervention studies for eczema
and food allergy showed positive results, but conflicting results were
presented in the remainder. Maternal
prebiotic studies also showed positive effects in both animal models and human
subjects, with offspring having greatly diminished expression of eczema. The observed variability of trial results is
analyzed with respect to study design, dosing, population and environmental
region.
Mechanically
prepared bacterial lysates (BL) for protection against respiratory illness is
also discussed in Pfefferle et al.
Observations that BL push upper airway responses toward Th1 maturation
were the basis for studies that examined the effect of BL in reducing the
incidence of acute respiratory tract infections (ARTI). Results showed a protective effect of BL,
especially in high risk children. The
authors comment that ARTI and recurrent wheeze in childhood is associated with
the development of asthma and suggest that BL may be a future focus of asthma
prevention research.
Pfefferle
et al. concludes noting that both the intrinsic and extrinsic microbial
environment are implicated in almost all inflammatory NCD and suggest that
methods of microbial manipulation are an important focus of future research
aimed at prevention strategies.